← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 1, 2002Last known activity
Oct 1, 2013
Timeline
1860s
- Jun 1, 1869
Manhattan Eye, Ear & Throat Hospital— Founded
Drugs by trial phase (6 distinct, 17 trials)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Central Serous Chorioretinopathy
- Choroiditis
- Communicable Diseases
- Diabetic Retinopathy
- Eye Diseases
- Eye Injuries
- Infections
- Inflammation
- Macular Degeneration
- Myopia, Degenerative
- Neovascularization, Pathologic
- Pseudoxanthoma Elasticum
- Retinal Diseases
- Retinal Telangiectasis
- Retinal Vein Occlusion
- Telangiectasis
- Vitelliform Macular Dystrophy
- von Hippel-Lindau Disease
- Wet Macular Degeneration
Recent trials (36)
- NCT01965041Lead sponsorN/AOct 1, 2013
- NCT01974622Lead sponsorN/AApr 1, 2013
- NCT00211432Overall official - principal investigatorPhase 2Apr 1, 2008
- NCT00211432Reponsible party - principal investigatorPhase 2Apr 1, 2008
- NCT00211432Lead sponsorPhase 2Apr 1, 2008
- NCT00489840Reponsible party - principal investigatorPhase 1/Phase 2May 1, 2007
- NCT00470977Lead sponsorPhase 1/Phase 2May 1, 2007
- NCT00470977Reponsible party - principal investigatorPhase 1/Phase 2May 1, 2007
- NCT00489840Overall official - principal investigatorPhase 1/Phase 2May 1, 2007
- NCT00489840Lead sponsorPhase 1/Phase 2May 1, 2007
- NCT00211406Lead sponsorPhase 1Sep 13, 2005
- NCT00211406Overall official - principal investigatorPhase 1Sep 13, 2005
- NCT00211419Lead sponsorPhase 1Sep 13, 2005
- NCT00211419Overall official - principal investigatorPhase 1Sep 13, 2005
- NCT00211458Overall official - principal investigatorPhase 2Sep 1, 2005
Details
- Founded
- New York, NY, US Jun 1, 1869
- Last known activity
- Oct 1, 2013